THIS PAGE IS INTENDED FOR THE GENERAL PUBLIC AND HEALTHCARE PROFESSIONALS
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.
YES NOUKBED-N/A-2500047 / June 2025
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.
YES NOUKBED-N/A-2500047 / June 2025
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you accept that you are a US healthcare professional and will be taken to US promotional content that is independent and not controlled by the owner of this website.
ACCEPT and go to www.axumin.comACCEPT and go to www.posluma.com
NO, I AM A PATIENT OR MEMBER OF THE GENERAL PUBLIC
NO, I AM A NON-US HEALTHCARE PROFESSIONAL
CANCEL
UKBED-N/A-2500026 / May 2025
You are leaving the Blue Earth Diagnostics corporate website. By clicking on this link, you acknowledge that you are an HCP from the Republic of Korea and will be redirected to promotional content that is independent and not controlled by the owner of this website.
YES NOUKBED-N/A-2600004 / January 2026
PRODUCTS
Below is a list of our products, and their availability. Not all products are available/approved in all countries. Any information shared is provided in line with local regulations. Due to regulatory requirements, we are unable to provide detailed information on our website. In markets where Blue Earth Diagnostics is not the marketing authorisation holder, the company has been responsible for development of products, but it is not involved in the promotion of products there.
|
TRADEMARK
|
GENERIC NAME
|
PRODUCT AREA
|
LICENSED
|
MARKETING AUTHORISATION HOLDER
|
PATIENTS
|
HCPs
|
|
Axumin |
fluciclovine F 18 injection |
Oncology |
US |
Blue Earth Diagnostics Ltd |
For patients based in the US, click here for more information |
For HCPs based in the US, click here for more information |
|
Axumin |
fluciclovine (18F) |
Oncology |
Europe |
Blue Earth Diagnostics Ireland Ltd |
For patients based in Europe, click here for more information |
For HCPs based in Europe, click here for more information |
|
Axumin |
fluciclovine (18F) |
Oncology |
UK |
Blue Earth Diagnostics Ltd |
For patients based in the UK, click here for more information |
For HCPs based in the UK, click here for more information |
|
Axumin |
fluciclovine (18F) |
Oncology |
Taiwan |
Global Medical Solutions Taiwan Ltd |
For patients based in Taiwan, click here for more information |
For HCPs based in the Taiwan, click here for more information |
|
Axumin |
fluciclovine (18F) |
Oncology |
Japan |
Nihon Medi-Physics Co Ltd |
For patients based in Japan, click here for more information |
For HCPs based in the Japan, click here for more information |
|
FACBC |
fluciclovine (18F) |
Oncology |
Republic of Korea |
DuchemBio Co Ltd |
For patients based in the Republic of Korea, click here for more information |
For HCPs based in the Republic of Korea, click here for more information |
|
Posluma |
flotufolastat F 18 injection |
Oncology |
US |
Blue Earth Diagnostics Ltd |
For patients based in the US, click here for more information |
For HCPs based in the US, click here for more information |
|
Prostaseek |
flotufolastat F 18 injection |
Oncology |
Republic of Korea |
DuchemBio Co Ltd |
For patients based in the Republic of Korea, click here for more information |
For HCPs based in the Republic of Korea, click here for more information |
UKBED-N/A-2600002 / March 2026
